Clinical Research Of Nourish Blood And Moisten Dryness Treatment On Erythroderma Psoriaticum And The Influence On T Cells Subsets

Objective:To observe the clinical efficacy of Nourish blood and Moisten dryness Treatment in Erythroderma Psoriaticum and the peripheral blood T cell subsets level changes,discussed the possible mechanism of Nourish blood and Moisten dryness Treatment in the treatment of Erythroderma Psoriaticum.Clinical research methods:Total 49 cases of patients with Erythroderma Psoriaticum were randomly divided into three groups:Acitretin Capsules group of 17 cases(control group),RunZaoYuFeng prescription group of 16 cases(treatment A group),RunZaoYuFeng prescription with Acitretin Capsules group of 16 cases(treatment B group).After three groups undergo a treatment period of 8 weeks,clinical efficacy was compared and peripheral blood T cell subsets level was measured.Results:Both the treatment A group and treatment B group embraced markedly clinical efficacy,compared to the control group,with significant difference.And,treatment B group was better than treatment A group.The recurrence rate of treatment B group was significantly lower than that of treatment A group.Prior to treatment,T cell subsets level in control group,treatment A group,treatment B group was significantly lower than that of normal control group.The T cell subsets level in each of the three group was significantly increased after the relevant treatment.Among the three different treated group,the T cell subsets level of treatment A group and treatment B group was significantly higher than that of control group,while that of treatment B group significantly higher that of treatment A group.Conclusion:Nourish blood and Moisten dryness Treatment exerted significant clinical efficacy on Erythroderma psoriaticum,and improved the immune balance of T cells subsets.